These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21129464)

  • 1. β-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria.
    Poulin JF; Caillard R; Subirade M
    Int J Pharm; 2011 Feb; 405(1-2):47-54. PubMed ID: 21129464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein based tablets as reversible gelling systems for delayed release applications.
    Caillard R; Subirade M
    Int J Pharm; 2012 Nov; 437(1-2):130-6. PubMed ID: 22846408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations.
    Calinescu C; Mulhbacher J; Nadeau E; Fairbrother JM; Mateescu MA
    Eur J Pharm Biopharm; 2005 May; 60(1):53-60. PubMed ID: 15848056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Delivery of Probiotics in Poultry Using pH-Sensitive Tablets.
    Jiang T; Li HS; Han GG; Singh B; Kang SK; Bok JD; Kim DD; Hong ZS; Choi YJ; Cho CS
    J Microbiol Biotechnol; 2017 Apr; 27(4):739-746. PubMed ID: 28081355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of gastro-resistant tablets for the protection and intestinal delivery of Lactobacillus fermentum CECT 5716.
    Villena MJ; Lara-Villoslada F; Martínez MA; Hernández ME
    Int J Pharm; 2015 Jun; 487(1-2):314-9. PubMed ID: 25843758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Delivery of Probiotics Using pH-Sensitive Phthalyl Inulin Tablets.
    Kim WS; Cho CS; Hong L; Han GG; Kil BJ; Kang SK; Kim DD; Choi YJ; Huh CS
    J Microbiol Biotechnol; 2019 Feb; 29(2):200-208. PubMed ID: 30691251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tablets containing probiotics: Effects of formulation and processing parameters on bacterial viability.
    Klayraung S; Viernstein H; Okonogi S
    Int J Pharm; 2009 Mar; 370(1-2):54-60. PubMed ID: 19059323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulation of a probiotic and prebiotic in alginate-chitosan capsules improves survival in simulated gastro-intestinal conditions.
    Chávarri M; Marañón I; Ares R; Ibáñez FC; Marzo F; Villarán Mdel C
    Int J Food Microbiol; 2010 Aug; 142(1-2):185-9. PubMed ID: 20659775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
    Calinescu C; Mateescu MA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis.
    Albertini B; Vitali B; Passerini N; Cruciani F; Di Sabatino M; Rodriguez L; Brigidi P
    Eur J Pharm Sci; 2010 Jul; 40(4):359-66. PubMed ID: 20420903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria and chocolate: a successful combination for probiotic delivery.
    Possemiers S; Marzorati M; Verstraete W; Van de Wiele T
    Int J Food Microbiol; 2010 Jun; 141(1-2):97-103. PubMed ID: 20452073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized tableting for extremely oxygen-sensitive probiotics using direct compression.
    Allouche R; Dupont S; Charriau A; Gervais P; Beney L; Chambin O
    Int J Pharm; 2018 Mar; 538(1-2):14-20. PubMed ID: 29307771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a formulation containing viable lactic acid bacteria.
    Stadler M; Viernstein H
    Int J Pharm; 2003 Apr; 256(1-2):117-22. PubMed ID: 12695017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions.
    Govender M; Choonara YE; van Vuuren S; Kumar P; du Toit LC; Pillay V
    J Pharm Pharmacol; 2015 Jul; 67(7):939-50. PubMed ID: 25645491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved viability of probiotics by encapsulation in chickpea protein matrix during simulated gastrointestinal digestion by succinylated modification.
    Yu H; Kong Q; Wang M; Han Z; Xu J
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129614. PubMed ID: 38246468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect.
    Park HJ; Lee GH; Jun J; Son M; Kang MJ
    Drug Des Devel Ther; 2016; 10():1355-64. PubMed ID: 27103789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria.
    Ding WK; Shah NP
    J Food Sci; 2007 Nov; 72(9):M446-50. PubMed ID: 18034741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylated high amylose starch as pharmaceutical excipients. Structural insights and formulation of pancreatic enzymes.
    Massicotte LP; Baille WE; Mateescu MA
    Int J Pharm; 2008 May; 356(1-2):212-23. PubMed ID: 18403141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.